Barriers and Facilitators toward HIV Testing and Health Perceptions among African-American Men Who Have Sex with Women at a South Side Chicago Community Health Center: A Pilot Study

Cooke, Ian J.; Jeremiah, Rohan D.; Moore, Nataka; Watson, Karriem S.; Dixon, Michael; Jordan, G. Lladó; Murray, Marcus; Keeter, Mary Kate; Hollowell, Courtney M.P.

doi:10.3389/fpubh.2016.00286

Cited by 9 publications

(9 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[26][27][28][29][30][31][32][33] HIVST is particularly relevant for stigmatized populations as it provides individuals with increased privacy and greater control over their testing needs. 34 The option to test privately at times and locations of choice creates the opportunity to reduce stigma, a significant barrier for MSM, [35][36][37][38][39] BMSM, 36,[39][40][41][42] sex workers, 43,44 prisoners, 45,46 and transgender women. 37,39,47 There is also evidence that HIVST may be acceptable for partner-testing by MSM 48 and transgender women 49 including transgender female sex workers.…”

Section: Introductionmentioning

confidence: 99%

<p>A Scoping Review of Patient Preferences for HIV Self-Testing Services in the United States: Implications for Harm Reduction</p>

Hawk¹,

Chung²,

Creasy³

et al. 2020

PPA

View full text Add to dashboard Cite

Purpose: Despite marked progress in the ability to test for, treat, and prevent HIV, the epidemic remains a significant public health concern, especially among key populations including prisoners; sex workers; transgender individuals; gay, bisexual, and other men who have sex with men (MSM); and Black and Latinx MSM. This scoping review was conducted to provide an overview of the current research describing patient preferences for HIVST in the United States to understand what key populations value about HIVST and why they are willing to use it. A targeted search for published literature on patient preferences for HIVST was conducted using Ovid Medline, PsychINFO, and an HIVST research database. Results: We reviewed 700 abstracts and 139 full texts. We found 19 articles published between January 2014 and April 2020 that included findings related to HIVST preferences. Overall, HIVST was preferred to more traditional testing. Six primary factors emerged as important HIVST values including: 1) convenience, 2) type of test; 3) cost, 4) stigma reduction, 5) risk reduction, and 6) self-control. Linkage to care was also identified as a key factor when considering HIVST as an option. Much of what makes HIVST attractive to individuals is their ability to self-determine how HIVST can be best integrated into their lives as a harm reduction tool for stigma and sexual risk mitigation. Conclusion: While there is substantial evidence suggesting HIVST is feasible for use and there are aspects of HIVST that are beneficial and preferred over traditional testing approaches, there is a lack of rigorous implementation studies exploring how best to scale up HIVST in community settings. HIVST has the potential to be a powerful biobehavioral HIV prevention and harm reduction tool to empower individuals to engage with testing on their own terms while providing pathways to prevention and care support.

show abstract

Section: Introductionmentioning

confidence: 99%

<p>A Scoping Review of Patient Preferences for HIV Self-Testing Services in the United States: Implications for Harm Reduction</p>

Hawk¹,

Chung²,

Creasy³

et al. 2020

PPA

View full text Add to dashboard Cite

show abstract

“…17 HIV stigma has been linked to diminished execution of HIV prevention strategies (safer sex, HIV testing), lower PrEP awareness, and lower PrEP uptake. [18][19][20][21] Furthermore, stigma and social marginalization related to sexuality, gender identity, and PrEP itself may impact HIV prevention and PrEP uptake among African American young adults. For example, enacted and internalized homophobia is linked to lower HIV testing rates among African American sexual minority men.…”

mentioning

confidence: 99%

A Qualitative Exploration of Various Stigmas Impacting HIV Pre-Exposure Prophylaxis (PrEP) Uptake Among African American Young Adults

Kerr

Ayangeakaa

Bullock

et al. 2022

Family &Amp; Community Health

View full text Add to dashboard Cite

Pre-exposure prophylaxis (PrEP) has promise for reducing racial/ethnic HIV disparities; yet, acceptance among African Americans remains low. PrEP-related stigmas may impact uptake, but this is understudied. This study examines mechanisms by which stigma impacts PrEP acceptance among various priority African American populations. Focus group data from 63 African American young adults (aged 18-29 years) in Louisville, Kentucky, explore how various stigmas impact attitudes toward PrEP. Data were analyzed using grounded theory analytic techniques. PrEP stigma, HIV stigma, sexual behavior stigma, and homophobia/transphobia individually reduce PrEP uptake. These stigmas also interact synergistically to undermine PrEP acceptance. Key challenges resulting from various stigmas and their interactions include medical hesitancy, lack of perceived susceptibility based on gender and sexuality, the role of gender norms in HIV prevention, and deprioritizing HIV prevention due to social rejection. Interventions to increase awareness, destigmatize PrEP, remediate social marginalization related to identity, HIV status, and gendered perceptions of sexual risk, as well as more focus on diverse priority groups, are needed to present PrEP as a viable HIV prevention option for African American communities. More research is needed to optimize strategies that address stigma and increase acceptance of novel HIV prevention technologies.

show abstract

“…RHLCCC-NU, CGHA, and UICC partners have worked together in more than 15 health fairs and PSA screening events and multiple PIs from PB, CGHA, UICC, and RHLCCC-NU have collaborated on previous projects with AA barbers to address HIV, PCa and mental health among AAM. 26,27…”

Section: Methodsmentioning

confidence: 99%

Engaging African American Men as Citizen Scientists to Validate a Prostate Cancer Biomarker: Work-in-Progress

Watson¹,

Henderson²,

Murray³

et al. 2019

Progress in Community Health Partnerships

Self Cite

View full text Add to dashboard Cite

Background African American men (AAM) are underrepresented in prostate cancer (PCa) research despite known disparities. Screening with prostate-specific antigen (PSA) has low specificity for high-grade PCa leading to PCa over diagnosis. The Prostate Health Index (PHI) has higher specificity for lethal PCa but needs validation in AAM. Engaging AAM as citizen scientists (CSs) may improve participation of AAM in PCa research. Objectives Assess feasibility of mobilizing CSs to recruit AAM as controls for PHI PCa validation biomarker study. Methods We highlight social networks/assets of stakeholders, CSs curriculum development/implementation, and recruitment of healthy controls for PHI validation. Results and Lessons Learned Eight CSs completed all training modules and 139 AAM were recruited. Challenges included equity in research leadership among multiple principal investigators (PIs) and coordinating CSs trainings. Conclusions Engaging AAM CSs can support engaging/recruiting AAM in PCa biomarker validation research. Equity among multiple stakeholders can be challenging, but proves beneficial in engaging AAM in research.

show abstract

Barriers and Facilitators toward HIV Testing and Health Perceptions among African-American Men Who Have Sex with Women at a South Side Chicago Community Health Center: A Pilot Study

Cited by 9 publications

References 22 publications

<p>A Scoping Review of Patient Preferences for HIV Self-Testing Services in the United States: Implications for Harm Reduction</p>

<p>A Scoping Review of Patient Preferences for HIV Self-Testing Services in the United States: Implications for Harm Reduction</p>

A Qualitative Exploration of Various Stigmas Impacting HIV Pre-Exposure Prophylaxis (PrEP) Uptake Among African American Young Adults

Engaging African American Men as Citizen Scientists to Validate a Prostate Cancer Biomarker: Work-in-Progress

Contact Info

Product

Resources

About